Joachim Geyer

Frankfurter Str. 98
Giessen, HE 35392, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Novel SOAT inhibitors block DHEAS transport and suppress proliferation in MCF-7 breast cancer cells.

Novel SOAT inhibitors block DHEAS transport and suppress proliferation in MCF-7 breast cancer cells.

Journal: Scientific reports

Published: January 19, 2026

Cloning, structural and functional characterization of the ABCB1 transporter of the Eurasian bullfinch (Pyrrhula pyrrhula).

Cloning, structural and functional characterization of the ABCB1 transporter of the Eurasian bullfinch (Pyrrhula pyrrhula).

Journal: Frontiers in veterinary science

Published: December 02, 2025

Functional Characterization of the Cat and Dog Wild-Type and Mutant MDR1 Carrier Proteins and Frequency of the MDR1 Gene Mutation in 800 Cats From Germany.

Functional Characterization of the Cat and Dog Wild-Type and Mutant MDR1 Carrier Proteins and Frequency of the MDR1 Gene Mutation in 800 Cats From Germany.

Journal: Journal of veterinary pharmacology and therapeutics

Published: October 21, 2025

Fluorescent 4-Nitrobenzo-2-oxa-1,3-diazole-Coupled Bile Acids as Probe Substrates of Hepatic and Intestinal Bile Acid Transporters of the Solute Carrier Families SLC10 and SLCO.

Fluorescent 4-Nitrobenzo-2-oxa-1,3-diazole-Coupled Bile Acids as Probe Substrates of Hepatic and Intestinal Bile Acid Transporters of the Solute Carrier Families SLC10 and SLCO.

Journal: Journal of medicinal chemistry

Published: May 17, 2025

Interaction between W41 of the hepatitis B virus preS1 surface peptide and Y146/F274 of the cellular receptor molecule Na+/taurocholate co-transporting polypeptide is essential for virus entry.

Interaction between W41 of the hepatitis B virus preS1 surface peptide and Y146/F274 of the cellular receptor molecule Na+/taurocholate co-transporting polypeptide is essential for virus entry.

Journal: Molecular pharmacology

Published: May 09, 2025

Carrier cross-reactivities of the bile acid reabsorption inhibitors elobixibat, linerixibat, maralixibat, and odevixibat.

Carrier cross-reactivities of the bile acid reabsorption inhibitors elobixibat, linerixibat, maralixibat, and odevixibat.

Journal: Journal of lipid research

Published: May 06, 2025

Intracrine Formation of Steroid Hormones in Breast Cancer, Epidermal Keratinocyte, Dermal Fibroblast, and Adipocyte Cell Lines Measured by LC-MS/MS.

Intracrine Formation of Steroid Hormones in Breast Cancer, Epidermal Keratinocyte, Dermal Fibroblast, and Adipocyte Cell Lines Measured by LC-MS/MS.

Journal: International journal of molecular sciences

Published: December 24, 2024

Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors.

Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitors.

Journal: Journal of hepatology

Published: December 19, 2024

Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT.

Structure-Activity Relationships and Target Selectivity of Phenylsulfonylamino-Benzanilide Inhibitors Based on S1647 at the SLC10 Carriers ASBT, NTCP, and SOAT.

Journal: Journal of medicinal chemistry

Published: October 17, 2024

Validation of NBD-coupled taurocholic acid for intravital analysis of bile acid transport in liver and kidney of mice.

Validation of NBD-coupled taurocholic acid for intravital analysis of bile acid transport in liver and kidney of mice.

Journal: EXCLI journal

Published: August 01, 2024

Quantitative bile acid profiling in healthy adult dogs and pups from serum, plasma, urine, and feces using LC-MS/MS.

Quantitative bile acid profiling in healthy adult dogs and pups from serum, plasma, urine, and feces using LC-MS/MS.

Journal: Frontiers in veterinary science

Published: February 02, 2024

Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP.

Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP.

Journal: Nature communications

Published: January 19, 2024

Showing 1-12 of 87

Last Updated: 09/26/2026